Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Lupus Landmark Study: A Prospective Registry and Biorepository

Lupus Nexus Landmark Study: A Prospective Registry and Biorepository

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Who May Be Eligible (Plain English)

Who May Qualify: - Able to understand and comply with study procedures and voluntarily sign a written willing to sign a consent form document - Age 18 years or older at the time of enrollment - Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Who Should NOT Join This Trial: - Not able to obtain consent - Not able to meet protocol visit requirements - Pregnant at the time of enrollment Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Able to understand and comply with study procedures and voluntarily sign a written informed consent document * Age 18 years or older at the time of enrollment * Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Exclusion Criteria: * Not able to obtain consent * Not able to meet protocol visit requirements * Pregnant at the time of enrollment

Locations (20)

University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Arizona
Tucson, Arizona, United States
Wallace Rheumatic Studies Center
Beverly Hills, California, United States
University of Miami
Miami, Florida, United States
Emory University
Atlanta, Georgia, United States
University of Chicago
Chicago, Illinois, United States
University of Massachusetts Memorial Health
Worcester, Massachusetts, United States
Washington University
St Louis, Missouri, United States
The Feinstein Institutes for Medical Research
Manhasset, New York, United States
Columbia University Medical Center
New York, New York, United States
Northwell Health
New York, New York, United States
SUNY Upstate
Syracuse, New York, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
The MetroHealth System
Cleveland, Ohio, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
UT Southwestern Medical Center
Dallas, Texas, United States
University of Calgary
Calgary, Alberta, Canada
University of Manitoba
Winnipeg, Manitoba, Canada
University Health Network/Toronto Western Hospital
Toronto, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada